Deadline draws near for nominations for inaugural Dan Haslam award by Steve Jones February 10, 2026June 8, 2026 Nominations for the inaugural Dan Haslam Memorial Award close on Friday with the recipient set to […]
Cannim liquidator draws up timeframe for potential litigation and court-ordered director examinations by Steve Jones February 10, 2026February 10, 2026
Tensions run high as creditors vote to wind up Cannim Group by Steve Jones February 5, 2026February 5, 2026
Spring Sciences Australia still weighing up IPO and funding options after ‘tough’ 2025 by Adam Sheldon February 5, 2026February 5, 2026
Biortica executive quits cannabis to return to pharma sector by Steve Jones February 4, 2026February 5, 2026
Cannatrek ‘evolution’ key to merger, says LGP managing director by Adam Sheldon February 3, 2026February 5, 2026
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent by Adam Sheldon February 2, 2026June 8, 2026
Cann Group to review guidance after starting post-NAB era with ‘unexpectedly’ soft revenue by Steve Jones January 30, 2026February 3, 2026
European growth helps LGP report record quarter of revenue by Steve Jones January 30, 2026February 3, 2026
